Patrick M. O'Connor, Ph.D., Selexagen Therapeutics (IMAGE)

American Association for Cancer Research

Patrick M. O'Connor, Ph.D., Selexagen Therapeutics

Caption

Patrick M. O'Connor, Ph.D., is chief scientific officer of Selexagen Therapeutics and editorial board member for Cancer Research.

Credit

Patrick M. O'Connor, Ph.D.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.